News

Moya joins us at an exciting stage for our Lateral Flow Development services. Moya brings over 15 years’ experience in Lateral Flow Assay development  and a reputation for excellence in the field, with technical lab expertise, project management skills, and proven leadership. She has a strong track record of taking assays from development through to manufacturing, across multiple sectors, assay types and deployment settings. In her new role she will lead projects from feasibi

We are excited to announce that Fleet Bioprocessing Ltd . are launching a new service: from today we will be offering contract development of lateral flow devices (LFDs) to our customers. LFDs form a cornerstone of modern diagnostics, providing a rapid means to detect diseases in a point-of-care (POC) format that can be used in people’s own homes or in primary care, with broader applications spanning clinical, veterinary, industrial and environmental settings. Traditionally

A frosty start to 2026 here at Pale Lane Farm - but we're all back at work and ready to discuss your New Year needs!

We received our annual ISO audit from NQA recently and I'm very pleased to say that once again we had zero non-conformances - an excellent result confirming that we have maintained our world class quality standards for another year. You can find our current ISO9001 and ISO13485 certificates here: Quality & GMP As well as applying our unparalleled technical and industry knowledge to your project, you can rest assured that all of Fleet Bioprocessing's work is carried out to the

Fleet Bioprocessing is pleased to celebrate its Silver Anniversary with 25 years in business. Fleet was founded in August 2000 by former members of Johnson and Johnson / Ortho Clinical Diagnostics' UK R&D group. Since then, Fleet has offered contract research, validation and manufacturing services to the diagnostics, pharmaceutical and life science research sector.

High-Performance Liquid Chromatography (HPLC) is a versatile technique for separating and identifying a diverse range of compounds. Initially aimed at analysing small molecules, advances in the technique have led to the ability to analyse larger molecules, such as antibodies and conjugates, making it a useful tool for the identification, characterization and purity testing of biological compounds. Fleet Bioprocessing is delighted to announce that we have recently expanded our

Fleet have recently expanded their analytical capabilities with the acquisition of a new HPLC instrument to support conjugation, purification and analytical projects. This asset has already been used to respond to an urgent request from an international diagnostics company based on the UK, to confirm that the purity of a panel of new reagent batches met their specifications. Please get in touch if this is of interest and would like to arrange a discussion - you can get in con

Fleet Bioprocessing has successfully been re-certified as meeting the standards of Cyber Essentials. Cyber Essentials is a Government backed scheme designed by the National Cyber Security Centre. By meeting the standards of Cyber Essentials, an organisation demonstrates that the defenses and controls in place will effectively protect against the vast majority of common cyber attacks.

Most of Fleet Bioprocessing Ltd.'s work is carried out under confidentiality agreements for commercial partners, therefore it never sees the light of day in publications. So we like to publicise it when our work does enter the public domain. Recently Fleet have been part of a team working with Somnus Scientific, Life Science Group, Creonate Manufacturing and AccentBio to develop immunoassays for propofol, which is a commonly-used anaesthetic for hospital procedures. It is adm

Further to our successful audit by NQA last month, we have now received our new certificates for ISO9001: 2015 and ISO13485: 2016, which are valid until 30th November 2027. You can download copies of these certificates here: https://www.fleetbioprocessing.co.uk/quality-gmp

We're delighted to report that our three-day recertification audit by NQA went very well last week, with not a single non-conformance or opportunity for improvement identified by the auditor. On the basis of this inspection, Fleet Bioprocessing Ltd. has been recommended for recertification to both ISO9001: 2015 and ISO13485: 2016 until November 2027 - which will take us to 27 years of uninterrupted compliance! For the first time ISO9001 compliance now requires companies like

Fleet Bioprocessing has successfully been re-certified as meeting the standards of Cyber Essentials. Cyber Essentials is a Government backed scheme designed by the National Cyber Security Centre. By meeting the standards of Cyber Essentials, an organisation demonstrates that the defenses and controls in place will effectively protect against the vast majority of common cyber attacks.

Recently, one of Fleet Bioprocessing’s experts was asked to consult on a project. Nothing unusual about that, Fleet experts regularly act as consultants for clients advising on bioconjugation , ELISA and assay development . Where this project differed was that the consultant was asked to provide expert witness testimony in an intellectual property dispute, culminating with taking the witness stand for cross examination in the High Court. Whilst quite different from our usual

At Fleet Bioprocessing Ltd., we take pride in being a Gyrolab Certified Assay Transfer and Development Partner. Fleet Bioprocessing Ltd. enjoys global recognition for our proficiency in bioconjugation chemistry. Our dedication to excellence has cemented our reputation as leaders in the field, trusted by clients worldwide. This complemented with our assay design expertise allows us to deliver reproducible and cost-effective critical reagents specifically designed for all your

At Fleet Bioprocessing we believe in the power of education and its role in shaping the next generation of talented scientists. Through our positive educational outreach efforts, we are happy to welcome aboard a new one year placement student from University of Surrey who will learn about immunoassays , bioconjugation and other related laboratory techniques. Our company has a long-standing tradition of engaging with and fostering efforts to support aspiring scientists. Worki

Fleet Bioprocessing has successfully been re-certified as meeting the standards of Cyber Essentials. Cyber Essentials is a Government backed scheme designed by the National Cyber Security Centre. By meeting the standards of Cyber Essentials, an organisation demonstrates that the defenses and controls in place will effectively protect against the vast majority of common cyber attacks.

Fleet Bioprocessing Ltd collaborated the National Physical Laboratory and the National Measurement Laboratory (at LGC Ltd) on a project investigating the characterisation of antibody conjugates for use in immunoassays. This work was published as "Impact of Bioconjugation on Structure and Function of Antibodies for Use in Immunoassay by Hydrogen-Deuterium Exchange Mass Spectrometry"(Luckau et al. Front. Mol. Biosci., 07 July 2022, Volume 9 - 2022), and has now been included in

Fleet Bioprocessing Ltd. are proud to report that we received zero non-conformances in our latest audit against the requirements of ISO9001: 2015 and ISO13485: 2016, which was carried out by NQA in December.

Fleet Bioprocessing's Director of Chemistry, Chris Blencowe, contributes to " Exploring the versatility of pentafulvene–maleimide cycloaddition as a ligation strategy: buffer and pH effects" published in Organic and Biomolecular Chemistry https://pubs.rsc.org/en/content/articlelanding/2022/OB/D2OB01453J

Fleet Bioprocessing Ltd. are proud to report that following an audit by NQA, we have been recertified to ISO9001: 2015 and ISO13485: 2016 until November 2024.